<TABLE>
<S> <C>
Pricing Supplement No. 2 dated August 14, 1998 Registration Nos. 333-38171
(To Prospectus dated August 7, 1998 and 333-38171-01
Prospectus Supplement dated August 7, 1998) Filing under Rule 424(b)(3)
FINOVA CAPITAL CORPORATION
Medium-Term Notes - Floating Rate
- ---------------------------------------------------------------------------------------------------------------------
Principal Amount: $25,000,000 Original Issue Date (Settlement Date): August 14, 1998
Stated Maturity: February 14, 2000
- ---------------------------------------------------------------------------------------------------------------------
Calculation Agent (If other than The First National Bank of Chicago):
Base Rate or Base Rates:
[_] CMT Rate [X] LIBOR
[_] Commercial Paper Rate [_] Prime Rate
[_] Eleventh District Cost of Funds Rate [_] Treasury Rate
[_] Federal Funds Rate [_] Other (see attached)
If LIBOR: If CMT Rate:
[_] LIBOR Reuters Designated CMT Telerate Page:
Page: If Telerate Page 7052:
[X] LIBOR Telerate [_] Weekly Average
Page: 3750 [_] Monthly Average
Designated LIBOR Currency: USD Designated CMT Maturity Index:
Interest Payment Date(s): November 14, February 14, Interest Rate Reset Period: Quarterly
May 14 and August 14 (following business Index Maturity: Quarterly
day convention applies) Spread (plus or minus): +.05%
Initial Interest Rate: 5.7375% Spread Multiplier: N/A
Interest Determination Date: second London Business Day before the Maximum Interest Rate: N/A
Interest Reset Date Minimum Interest Rate: N/A
Interest Reset Date(s): same as the Interest Payment Dates
Day Count Convention (if no Day Count Convention is specified below, the Day Count Convention from the Original Issue
Day until the principal of, premium, if any, and interest on the Medium-Term Notes offered hereby (the "Notes")
are paid in full will be as set forth in the Prospectus Supplement referred to above):
[X] Actual/360 for the period from August 14, 1998 to February 14, 2000
[_] Actual/Actual for the period from to
[_] 30/360 for the period from to
Applicable Base Rate:
Redemption:
[X] The Notes cannot be redeemed at the option of FINOVA CapitalCorporation (the "Company") prior to Stated
Maturity.
[_] The Notes may be redeemed at the option of the Company prior to Stated Maturity.
Initial Redemption Date:
Initial Redemption Percentage: %
Annual Redemption Percentage Reduction: % until the Redemption Price is 100% of the
Principal Amount.
Optional Repayment:
[X] The Notes cannot be repaid at the option of the Holders thereof prior to Stated Maturity.
[_] The Notes can be repaid at the option of the Holders thereof prior to Stated Maturity.
Optional Repayment Date(s):
Authorized Denomination (if other than $1,000 and integral multiples thereof):
<PAGE>
Original Issue Discount: [_] Yes [X] No
Total Amount of OID: Yield to Maturity:
Initial Accrual Period: Issue Price: %
Method used to determine yield for Initial Accrual Period:
[_] Approximate
[_] Exact
Form: [X] Book-Entry [_] Certificated
Agent: [_] Credit Suisse First Boston Corporation
[X] Goldman, Sachs & Co.
[_] Lehman Brothers Inc.
[_] Merrill Lynch & Co.
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
[_] Morgan Stanley & Co. Incorporated
[_] Salomon Brothers Inc
Agent is acting in the capacity indicated below:
[X] Agent [_] Principal
If as principal:
[_] The Notes are being offered at varying prices related to prevailing market prices at the time of
resale, plus accrued interest, if any, from the Original Issue Date.
[_] The Notes are being offered at a fixed initial public offering price of % of the Principal
Amount, plus accrued interest, if any, from the Original Issue Date.
If as agent:
The Notes are being offered at a fixed initial public offering price of 100% of the Principal Amount, plus
accrued interest, if any, from the Original Issue Date.
Agent's discount or commission: .20%
Net proceeds to Company: $24,950,000
Other Provisions:
Certain capitalized terms used in this Pricing Supplement and not defined herein have the respective meanings
ascribed thereto in the Prospectus and Prospectus Supplement referred to above.
</TABLE>
